Holen Sie sich die Stockscreener-App
43.44
0.06%
0.025
Schlusskurs vom Vortag:
$43.41
Offen:
$43.525
24-Stunden-Volumen:
1.80M
Relative Volume:
0.39
Marktkapitalisierung:
$35.29B
Einnahmen:
$28.43B
Nettoeinkommen (Verlust:
$1.16B
KGV:
30.04
EPS:
1.4457
Netto-Cashflow:
$1.26B
1W Leistung:
-2.15%
1M Leistung:
-4.10%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$42.65
$43.75
1-Wochen-Bereich:
$42.53
$44.53
52-Wochen-Spanne:
$38.50
$50.88
Medline Inc Stock (MDLN) Company Profile
Firmenname
Medline Inc
Sektor
Telefon
847-949-3000
Adresse
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
43.48 | 35.23B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ISRG
Intuitive Surgical Inc
|
488.87 | 175.28B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
164.73 | 47.07B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
81.36 | 39.90B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
248.05 | 36.85B | 5.40B | 1.49B | 1.78B | 10.12 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-05 | Eingeleitet | Tigress Financial | Buy |
| 2026-01-21 | Bestätigt | BTIG Research | Buy |
| 2026-01-12 | Eingeleitet | Citigroup | Buy |
| 2026-01-12 | Eingeleitet | Deutsche Bank | Hold |
| 2026-01-12 | Eingeleitet | Evercore ISI | Outperform |
| 2026-01-12 | Eingeleitet | Goldman | Buy |
| 2026-01-12 | Eingeleitet | JP Morgan | Overweight |
| 2026-01-12 | Eingeleitet | Jefferies | Buy |
| 2026-01-12 | Eingeleitet | Leerink Partners | Outperform |
| 2026-01-12 | Eingeleitet | Mizuho | Outperform |
| 2026-01-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2026-01-12 | Eingeleitet | Piper Sandler | Overweight |
| 2026-01-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2026-01-12 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2026-01-12 | Eingeleitet | Stifel | Buy |
| 2026-01-12 | Eingeleitet | TD Cowen | Buy |
| 2026-01-12 | Eingeleitet | Truist | Buy |
| 2026-01-12 | Eingeleitet | UBS | Buy |
| 2026-01-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2026-01-12 | Eingeleitet | William Blair | Outperform |
| 2026-01-12 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Medline Inc Aktie (MDLN) Neueste Nachrichten
Medline (MDLN) Q4 net sales rise 14.8% to $7.8B following completion of IPO - MSN
Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO - Insider Monkey
Medline Awards Distribution Center of the Year and SAFE Awards - marketscreener.com
Medline stock price target raised to $60 by Tigress Financial - Investing.com
Medline prices $3B secondary offering at $41 per share - MSN
Medline stock price target reaffirmed at $55 by BTIG - Investing.com
Medline Inc. announces pricing of secondary offering of class A common stock - Sahm
Medline’s buyout firm backers raise $3.1B in share sale - Crain's Chicago Business
Medline’s PE owners cash out US$3.1bn in early lockup release - ifre.com
Medline Secondary Common Stock Offering Prices; Shares Down Pre-Bell - marketscreener.com
Medline stockholders price secondary offering at $41 per share By Investing.com - Investing.com Australia
Medline stockholders price secondary offering at $41 per share - Investing.com
Medline’s Buyout Firm Backers Raise $3.1 Billion in Share Sale - Bloomberg.com
Medline Inc. Announces Pricing Of Secondary Offering Of Class A Common Stock - TradingView
Shareholders of the American Medline intend to sell shares worth $ 3.4 billion - AKM.RU
Ear Syringe Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Medline Backers Launch $3.4B Secondary Sale Near Chicago - Hoodline
Blackstone, Carlyle, Hellman & Friedman Offer 75M Shares For MedlineMedline (NASDAQ:MDLN) - Benzinga
Medline’s PE backers start stake sale worth $3.4 billion - Crain's Chicago Business
Medline Shareholders Seek $3.4 Billion Stake Sale - Transport Topics
Medline’s PE Backers Start Stake Sale Worth $3.4 Billion - Bloomberg
Medline stockholders launch 75 million share offering - Investing.com
Medline shares fall 4.4% as major investors launch secondary offering By Investing.com - Investing.com Nigeria
Medline stockholders launch 75 million share offering By Investing.com - Investing.com Canada
Medline announces $3.6B secondary offering from private equity firms - MassDevice
Medline Inc. announces launch of secondary offering of Class A common stock - GlobeNewswire
Form S-1 Medline Inc. - StreetInsider
USA Herald - USA Herald
The 20+ Club: Ron Woosley - Medline Newsroom
Medline expands AI platform and warehouse robotics - Digital Commerce 360
Medline Inc.: Fundamental Analysis and Financial Ratings | MDLN | US58507V1070 - marketscreener.com
The Analyst Verdict: Medline In The Eyes Of 29 Experts - Benzinga
Wells Fargo & Company Increases Medline (NASDAQ:MDLN) Price Target to $47.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN) - The Globe and Mail
Medline Inc (MDLN) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Innovations ... By GuruFocus - Investing.com Canada
Medline Analysts Boost Their Forecasts Following Q4 Results - Benzinga
Medline (NASDAQ:MDLN) Given New $54.00 Price Target at BMO Capital Markets - MarketBeat
Medline boasts $2.4B in new customer signings in 2025 - HME News
Wolfe Research raises Medline stock price target on revenue beat By Investing.com - Investing.com India
Wolfe Research raises Medline stock price target on revenue beat - Investing.com
CEO of Northfield-based Medline talks tariffs, IPO following company’s first earnings call - Chicago Tribune
Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… - marketscreener.com
Evercore ISI Maintains Outperform on Medline Inc (MDLN) Feb 25 2026 - Meyka
Medline's first quarter as a public company ends with rising sales, dip in income - Crain's Chicago Business
Medline Inc. SEC 10-K Report - TradingView
Stifel raises Medline stock price target to $55 on strong results - Investing.com
Medline Q4 Earnings Call Highlights - MarketBeat
Evercore ISI raises Medline stock price target on strong momentum By Investing.com - Investing.com South Africa
Evercore ISI raises Medline stock price target on strong momentum - Investing.com
Robust Q4 Beat and Underappreciated 2026 Upside Support Buy Rating on Medline - TipRanks
Finanzdaten der Medline Inc-Aktie (MDLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):